An Integrated Mathematical Model of Thrombin-, Histamine-and VEGF-Mediated Signalling in Endothelial Permeability

BMC Systems Biology

Volumn 5, Issue , 2011, Pages

  Wei, X N ^a,b   Han, B C ^a   Zhang, J X ^a   Liu, X H ^a   Tan, C Y ^b   Jiang, Y Y ^b   Low, B C ^a,c   Tidor, B ^a,d,e   Chen, Y Z ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TSINGHUA UNIVERSITY   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d USA   (United States)

^e SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALMODULIN; HISTAMINE; INOSITOL 1,4,5 TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; MUSCLE PROTEIN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PHOSPHOPROTEIN; PPP1R14A PROTEIN, MOUSE; PROTEINASE ACTIVATED RECEPTOR 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; THROMBIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL STRAIN 3T3; CYTOLOGY; ENDOTHELIUM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MOUSE; PERMEABILITY; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CALMODULIN; ENDOTHELIUM; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HISTAMINE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; MICE; MODELS, BIOLOGICAL; MUSCLE PROTEINS; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; NIH 3T3 CELLS; PERMEABILITY; PHOSPHOPROTEINS; RECEPTOR, PAR-1; REPRODUCIBILITY OF RESULTS; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; THROMBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79960558433     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-5-112     Document Type: Article

References (100)

1. Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 2006, 10:355-362. 10.1016/j.ccr.2006.10.002, 17097558.
2. Martorell L, Martinez-Gonzalez J, Rodriguez C, Gentile M, Calvayrac O, Badimon L. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 2008, 99:305-315.
3. Finigan JH. The coagulation system and pulmonary endothelial function in acute lung injury. Microvasc Res 2009, 77:35-38. 10.1016/j.mvr.2008.09.002, 18938186.
4. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med 2009, 11:e19. 2828491, 19563700.
5. Jutel M, Blaser K, Akdis CA. The role of histamine in regulation of immune responses. Chem Immunol Allergy 2006, 91:174-187.
6. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000, 407:258-264. 10.1038/35025229, 11001069.
7. van Nieuw Amerongen GP, Draijer R, Vermeer MA, van Hinsbergh VW. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ Res 1998, 83:1115-1123.
8. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989, 246:1309-1312. 10.1126/science.2479987, 2479987.
9. Sun H, Breslin JW, Zhu J, Yuan SY, Wu MH. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 2006, 13:237-247. 10.1080/10739680600556944, 16627366.
10. Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007, 28:297-321. 10.1210/er.2006-0027, 17409287.
11. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008, 1123:134-145. 10.1196/annals.1420.016, 18375586.
12. Hirano K, Derkach DN, Hirano M, Nishimura J, Kanaide H. Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain. Mol Cell Biochem 2003, 248:105-114. 10.1023/A:1024180101032, 12870661.
13. Wang L, Dudek SM. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 2009, 77:39-45. 10.1016/j.mvr.2008.09.005, 2693384, 18973762.
14. Hu G, Minshall RD. Regulation of transendothelial permeability by Src kinase. Microvasc Res 2009, 77:21-25. 10.1016/j.mvr.2008.10.002, 19027754.
15. Lukas TJ. A signal transduction pathway model prototype I: From agonist to cellular endpoint. Biophys J 2004, 87:1406-1416. 10.1529/biophysj.103.035253, 1304549, 15345523.
16. Lukas TJ. A signal transduction pathway model prototype II: Application to Ca2+-calmodulin signaling and myosin light chain phosphorylation. Biophys J 2004, 87:1417-1425. 10.1529/biophysj.104.042721, 1304550, 15345524.
17. Moraru II, Loew LM. Intracellular signaling: spatial and temporal control. Physiology (Bethesda) 2005, 20:169-179.
18. Maeda A, Ozaki Y, Sivakumaran S, Akiyama T, Urakubo H, Usami A, Sato M, Kaibuchi K, Kuroda S. Ca2+ -independent phospholipase A2-dependent sustained Rho-kinase activation exhibits all-or-none response. Genes Cells 2006, 11:1071-1083. 10.1111/j.1365-2443.2006.01001.x, 16923126.
19. Viswanathan GA, Seto J, Patil S, Nudelman G, Sealfon SC. Getting started in biological pathway construction and analysis. PLoS Comput Biol 2008, 4:e16. 10.1371/journal.pcbi.0040016, 2323403, 18463709.
20. van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 2002, 39:257-272. 10.1016/S1537-1891(03)00014-4, 12747965.
21. Fajmut A, Dobovisek A, Brumen M. Mathematical modeling of the relation between myosin phosphorylation and stress development in smooth muscles. J Chem Inf Model 2005, 45:1610-1615. 10.1021/ci050178a, 16309262.
22. Caunt M, Hu L, Tang T, Brooks PC, Ibrahim S, Karpatkin S. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res 2006, 66:4125-4132. 10.1158/0008-5472.CAN-05-2570, 16618733.
23. Zania P, Papaconstantinou M, Flordellis CS, Maragoudakis ME, Tsopanoglou NE. Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms. Am J Physiol Cell Physiol 2008, 294:C1215-1226. 10.1152/ajpcell.00452.2007, 18367587.
24. Grand RJ, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 1996, 313(Pt 2):353-368. 1216916, 8573065.
25. Vouret-Craviari V, Van Obberghen-Schilling E, Rasmussen UB, Pavirani A, Lecocq JP, Pouyssegur J. Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell 1992, 3:95-102. 275505, 1312881.
26. Parry MA, Myles T, Tschopp J, Stone SR. Cleavage of the thrombin receptor: identification of potential activators and inactivators. Biochem J 1996, 320(Pt 1):335-341. 1217936, 8947506.
27. Buhl AM, Johnson NL, Dhanasekaran N, Johnson GL. G alpha 12 and G alpha 13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J Biol Chem 1995, 270:24631-24634. 10.1074/jbc.270.42.24631, 7559569.
28. Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol 1999, 71:479-500. 10.1016/S0079-6107(98)00056-X, 10354710.
29. Aixinjueluo W, Furukawa K, Zhang Q, Hamamura K, Tokuda N, Yoshida S, Ueda R. Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis. J Biol Chem 2005, 280:29828-29836. 10.1074/jbc.M414041200, 15923178.
30. Shoemaker MO, Lau W, Shattuck RL, Kwiatkowski AP, Matrisian PE, Guerra-Santos L, Wilson E, Lukas TJ, Van Eldik LJ, Watterson DM. Use of DNA sequence and mutant analyses and antisense oligodeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity. J Cell Biol 1990, 111:1107-1125. 10.1083/jcb.111.3.1107, 2116294, 2202734.
31. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997, 137:481-492. 10.1083/jcb.137.2.481, 2139771, 9128257.
32. Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, Spreafico F, Pausa M, D'Ettorre C, Gianazza E, Tagliabue A, Salmona M, Tedesco F, Introna M, Mantovani A. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997, 272:32817-32823. 10.1074/jbc.272.52.32817, 9407058.
33. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990, 87:682-685. 10.1073/pnas.87.2.682, 53329, 1689048.
34. Lin S, Fagan KA, Li KX, Shaul PW, Cooper DM, Rodman DM. Sustained endothelial nitric-oxide synthase activation requires capacitative Ca2+ entry. J Biol Chem 2000, 275:17979-17985. 10.1074/jbc.275.24.17979, 10849433.
35. Noiri E, Lee E, Testa J, Quigley J, Colflesh D, Keese CR, Giaever I, Goligorsky MS. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol 1998, 274:C236-244.
36. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997, 99:2625-2634. 10.1172/JCI119451, 508108, 9169492.
37. Hood J, Granger HJ. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 1998, 273:23504-23508. 10.1074/jbc.273.36.23504, 9722588.
38. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 1985, 25:593-620. 10.1146/annurev.pa.25.040185.003113, 2988424.
39. Moussavi RS, Kelley CA, Adelstein RS. Phosphorylation of vertebrate nonmuscle and smooth muscle myosin heavy chains and light chains. Mol Cell Biochem 1993, 127-128:219-227. 10.1007/BF01076773, 7935353.
40. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994, 372:231-236. 10.1038/372231a0, 7969467.
41. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996, 271:20246-20249. 10.1074/jbc.271.34.20246, 8702756.
42. Hartshorne DJ, Ito M, Erdodi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 1998, 19:325-341. 10.1023/A:1005385302064, 9635276.
43. Alessi D, MacDougall LK, Sola MM, Ikebe M, Cohen P. The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur J Biochem 1992, 210:1023-1035. 10.1111/j.1432-1033.1992.tb17508.x, 1336455.
44. Shirazi A, Iizuka K, Fadden P, Mosse C, Somlyo AP, Somlyo AV, Haystead TA. Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle. J Biol Chem 1994, 269:31598-31606.
45. Johnson D, Cohen P, Chen MX, Chen YH, Cohen PT. Identification of the regions on the M110 subunit of protein phosphatase 1 M that interact with the M21 subunit and with myosin. Eur J Biochem 1997, 244:931-939. 10.1111/j.1432-1033.1997.00931.x, 9108268.
46. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996, 273:245-248. 10.1126/science.273.5272.245, 8662509.
47. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem 1995, 118:1104-1107.
48. Goeckeler ZM, Wysolmerski RB. Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol 1995, 130:613-627. 10.1083/jcb.130.3.613, 2120532, 7622562.
49. Kolodney MS, Elson EL. Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J Biol Chem 1993, 268:23850-23855.
50. Zhi G, Ryder JW, Huang J, Ding P, Chen Y, Zhao Y, Kamm KE, Stull JT. Myosin light chain kinase and myosin phosphorylation effect frequency-dependent potentiation of skeletal muscle contraction. Proc Natl Acad Sci USA 2005, 102:17519-17524. 10.1073/pnas.0506846102, 1297671, 16299103.
51. Benardeau A, Hatem SN, Rucker-Martin C, Le Grand B, Mace L, Dervanian P, Mercadier JJ, Coraboeuf E. Contribution of Na+/Ca2+ exchange to action potential of human atrial myocytes. Am J Physiol 1996, 271:H1151-1161.
52. Tran QK, Watanabe H. Calcium signalling in the endothelium. Handb Exp Pharmacol 2006, 145-187.
53. Jeng JH, Chan CP, Wu HL, Ho YS, Lee JJ, Liao CH, Chang YK, Chang HH, Chen YJ, Perng PJ, Chang MC. Protease-activated receptor-1-induced calcium signaling in gingival fibroblasts is mediated by sarcoplasmic reticulum calcium release and extracellular calcium influx. Cell Signal 2004, 16:731-740. 10.1016/j.cellsig.2003.11.008, 15093614.
54. Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JG, Verin AD. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc Res 2004, 67:64-77. 10.1016/j.mvr.2003.09.007, 14709404.
55. Yazaki A, Tamaru S, Sasaki Y, Komatsu N, Wada H, Shiku H, Nishikawa M. Inhibition by Rho-kinase and protein kinase C of myosin phosphatase is involved in thrombin-induced shape change of megakaryocytic leukemia cell line UT-7/TPO. Cell Signal 2005, 17:321-330. 10.1016/j.cellsig.2004.07.009, 15567063.
56. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, Ito M. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 1997, 272:12257-12260. 10.1074/jbc.272.19.12257, 9139666.
57. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985. 10.1126/science.6823562, 6823562.
58. Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW, Duran WN. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 2003, 284:H92-H100.
59. Nelken NA, Soifer SJ, O'Keefe J, Vu TK, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 1992, 90:1614-1621. 10.1172/JCI116031, 443210, 1328304.
60. Tellez C, Bar-Eli M. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 2003, 22:3130-3137. 10.1038/sj.onc.1206453, 12789289.
61. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998, 4:909-914. 10.1038/nm0898-909, 9701242.
62. Jin HG, Yamashita H, Nagano Y, Fukuba H, Hiji M, Ohtsuki T, Takahashi T, Kohriyama T, Kaibuchi K, Matsumoto M. Hypoxia-induced upregulation of endothelial small G protein RhoA and Rho-kinase/ROCK2 inhibits eNOS expression. Neurosci Lett 2006, 408:62-67. 10.1016/j.neulet.2006.08.038, 16996686.
63. Li B, Zhao WD, Tan ZM, Fang WG, Zhu L, Chen YH. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 2006, 580:4252-4260. 10.1016/j.febslet.2006.06.056, 16828752.
64. Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 1997, 32:175-253. 10.3109/10409239709082573, 9239493.
65. Worthylake RA, Lemoine S, Watson JM, Burridge K. RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol 2001, 154:147-160. 10.1083/jcb.200103048, 2196864, 11448997.
66. Adamson P, Etienne S, Couraud PO, Calder V, Greenwood J. Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway. J Immunol 1999, 162:2964-2973.
67. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676. 10.1038/nm0603-669, 12778165.
68. Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med 1998, 25:891-897. 10.1016/S0891-5849(98)00115-4, 9840733.
69. Fiallo P, Clapasson A, Favre A, Pesce C. Overexpression of vascular endothelial growth factor and its endothelial cell receptor KDR in type 1 leprosy reaction. Am J Trop Med Hyg 2002, 66:180-185.
70. Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 2005, 6:511-524. 10.2174/1389450054021981, 16026270.
71. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999, 5:1359-1364. 10.1038/70928, 10581076.
72. Padro T, Bieker R, Ruiz S, Steins M, Retzlaff S, Burger H, Buchner T, Kessler T, Herrera F, Kienast J, Müller-Tidow C, Serve H, Berdel WE, Mesters RM. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 2002, 16:1302-1310. 10.1038/sj.leu.2402534, 12094254.
73. Beynon HL, Haskard DO, Davies KA, Haroutunian R, Walport MJ. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol 1993, 91:314-319. 1554683, 8428396.
74. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003, 4:446-456. 10.1038/nrm1128, 12778124.
75. Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 2005, 26:178-182. 10.1016/j.tips.2005.02.007, 15808341.
76. Maragoudakis ME, Tsopanoglou NE, Andriopoulou P, Maragoudakis MM. Effects of thrombin/thrombosis in angiogenesis and tumour progression. Matrix Biol 2000, 19:345-351. 10.1016/S0945-053X(00)00079-2, 10963995.
77. Roselli M, Mineo TC, Basili S, Mariotti S, Martini F, Bellotti A, Ambrogi V, Spila A, D'Alessandro R, Gazzaniga PP, Guadagni F, Ferroni P. Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers. Thromb Haemost 2003, 89:177-184.
78. Gieseler F, Luhr I, Kunze T, Mundhenke C, Maass N, Erhart T, Denker M, Beckmann D, Tiemann M, Schulte C, Dohrmann P, Cavaillé F, Godeau F, Gespach C. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Thromb Haemost 2007, 97:1023-1030.
79. MacDonald JA, Eto M, Borman MA, Brautigan DL, Haystead TA. Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase. FEBS Lett 2001, 493:91-94. 10.1016/S0014-5793(01)02277-3, 11287002.
80. Ohama T, Hori M, Sato K, Ozaki H, Karaki H. Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J Biol Chem 2003, 278:48794-48804. 10.1074/jbc.M310166200, 14512413.
81. Sakai H, Chiba Y, Hirano T, Misawa M. Possible involvement of CPI-17 in augmented bronchial smooth muscle contraction in antigen-induced airway hyper-responsive rats. Mol Pharmacol 2005, 68:145-151.
82. Dakshinamurti S, Mellow L, Stephens NL. Regulation of pulmonary arterial myosin phosphatase activity in neonatal circulatory transition and in hypoxic pulmonary hypertension: a role for CPI-17. Pediatr Pulmonol 2005, 40:398-407. 10.1002/ppul.20290, 16130142.
83. Chang S, Hypolite JA, DiSanto ME, Changolkar A, Wein AJ, Chacko S. Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase beta and CPI-17. Am J Physiol Renal Physiol 2006, 290:F650-656.
84. Woodsome TP, Eto M, Everett A, Brautigan DL, Kitazawa T. Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol 2001, 535:553-564. 10.1111/j.1469-7793.2001.t01-1-00553.x, 2278797, 11533144.
85. Aslam M, Hartel FV, Arshad M, Gunduz D, Abdallah Y, Sauer H, Piper HM, Noll T. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17. Cardiovasc Res 2010, 87:375-384. 10.1093/cvr/cvq065, 20202976.
86. Wang W, Merrill MJ, Borchardt RT. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am J Physiol 1996, 271:C1973-1980.
87. Braun P, Tasan M, Dreze M, Barrios-Rodiles M, Lemmens I, Yu H, Sahalie JM, Murray RR, Roncari L, de Smet AS, Venkatesan K, Rual JF, Vandenhaute J, Cusick ME, Pawson T, Hill DE, Tavernier J, Wrana JL, Roth FP, Vidal M. An experimentally derived confidence score for binary protein-protein interactions. Nat Methods 2009, 6:91-97. 10.1038/nmeth.1281, 2976677, 19060903.
88. Kholodenko BN, Demin OV, Moehren G, Hoek JB. Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 1999, 274:30169-30181. 10.1074/jbc.274.42.30169, 10514507.
89. Schoeberl B, Eichler-Jonsson C, Gilles ED, Muller G. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol 2002, 20:370-375. 10.1038/nbt0402-370, 11923843.
90. Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Novère NL, Laibe C. BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol 2010, 4:92. 10.1186/1752-0509-4-92, 2909940, 20587024.
91. Kumar P, Han BC, Shi Z, Jia J, Wang YP, Zhang YT, Liang L, Liu QF, Ji ZL, Chen YZ. Update of KDBI: Kinetic Data of Bio-molecular Interaction database. Nucleic Acids Res 2009, 37:D636-641. 10.1093/nar/gkn839, 2686478, 18971255.
92. Singhal M, Resat H. A domain-based approach to predict protein-protein interactions. BMC Bioinformatics 2007, 8:199. 10.1186/1471-2105-8-199, 1919395, 17567909.
93. Wojcik J, Schachter V. Protein-protein interaction map inference using interacting domain profile pairs. Bioinformatics 2001, 17(Suppl 1):S296-305. 10.1093/bioinformatics/17.suppl_1.S296, 11473021.
94. Coleman TF, Li YY. An interior trust region approach for nonlinear minimization subject to bounds. Siam J Optimiz 1996, 6:418-445.
95. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, Ito M, Matsumura F, Inagaki M, Kaibuchi K. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 1999, 147:1023-1038. 10.1083/jcb.147.5.1023, 2169354, 10579722.
96. Sasagawa S, Ozaki Y, Fujita K, Kuroda S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 2005, 7:365-373. 10.1038/ncb1233, 15793571.
97. Dimopoulos GJ, Semba S, Kitazawa K, Eto M, Kitazawa T. Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle. Circ Res 2007, 100:121-129. 10.1161/01.RES.0000253902.90489.df, 2212616, 17158339.
98. Cameron AC, Windmeijer FAG. An R-squared measure of goodness of fit for some common nonlinear regression models. J Econometrics 1997, 77:329-342.
99. Hamby DM. A Review of Techniques for Parameter Sensitivity Analysis of Environmental-Models. Environ Monit Assess 1994, 32:135-154.
100. Martins JRRA, Sturdza P, Alonso JJ. The complex-step derivative approximation. Acm T Math Software 2003, 29:245-262.